Thrombophilic Variables Do Not Increase the Generation or Procoagulant Activity of Thrombin During Cardiopulmonary Bypass

Annals of Thoracic Surgery

Volumn 85, Issue 2, 2008, Pages 536-542

  Raivio, Peter ^a   Petäjä, Jari ^b   Kuitunen, Anne ^a   Lassila, Riitta ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b JORVI HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRIN; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FIBRINOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCREENING TEST; THROMBOPHILIA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARDIOPULMONARY BYPASS; COHORT STUDIES; CONFIDENCE INTERVALS; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEPTIDE FRAGMENTS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROTEIN PRECURSORS; PROTHROMBIN; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; THROMBIN; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 38349183048     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.09.045     Document Type: Article

References (37)

1. Burns P.J., Mosquera D.A., and Bradbury A.W. Prevalence and significance of thrombophilia in peripheral arterial disease. Eur J Vasc Endovasc Surg 22 (2001) 98-106
2. Sofi F., Lari B., Rogolino A., et al. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg 41 (2005) 255-260
3. Marcucci R., Sofi F., Fedi S., et al. Thrombophilic risk factors in patients with severe carotid atherosclerosis. J Thromb Haemost 3 (2005) 502-507
4. Lowe G.D. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3 (2005) 1618-1627
5. Ye Z., Liu E.H., Higgins J.P., et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 367 (2006) 651-658
6. Poort S.R., Rosendaal F.R., Reitsma P.H., and Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
7. Zöller B., Holm J., Svensson P., and Dahlbäck B. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency. Thromb Haemost 75 (1996) 270-274
8. Bauer K.A., Broekmans A.W., Bertina R.M., et al. Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood 71 (1988) 1418-1426
9. Mannucci P.M., Tripodi A., Bottasso B., et al. Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes. Thromb Haemost 67 (1992) 200-202
10. Regnault V., Hemker H.C., Wahl D., and Lecompte T. Phenotyping the haemostatic system by thrombography - potential for the estimation of thrombotic risk. Thromb Res 114 (2004) 539-545
11. Boisclair M.D., Lane D.A., Philippou H., et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 82 (1993) 3350-3357
12. Petäjä J., Pesonen E., Fernández J.A., Vento A.E., Rämö O.J., and Griffin J.H. Cardiopulmonary bypass and activation of antithrombotic plasma protein C. J Thorac Cardiovasc Surg 118 (1999) 422-429
13. Chandler W.L., and Velan T. Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. Blood 101 (2003) 4355-4362
14. Raivio P., Kuitunen A., Suojaranta-Ylinen R., Lassila R., and Petäjä J. Thrombin generation during reperfusion after coronary artery bypass surgery associates with postoperative myocardial damage. J Thromb Haemost 4 (2006) 1523-1529
15. Dixon B., Santamaria J., and Campbell D. Coagulation activation and organ dysfunction following cardiac surgery. Chest 128 (2005) 229-236
16. Raivio P., Fernández J.A., Kuitunen A., Griffin J.H., Lassila R., and Petäjä J. Activation of protein C and hemodynamic recovery after coronary artery bypass surgery. J Thorac Cardiovasc Surg 133 (2007) 44-51
17. De Stefano V., Finazzi G., and Mannucci P.M. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 87 (1996) 3531-3544
18. Tran M., and Spencer F.A. Thromboepidemiology: identifying patients with heritable risk for thrombin-mediated thromboembolic events. Am Heart J 149 (2005) S9-S18
19. Edmunds Jr. L.H., and Colman R.W. Thrombin during cardiopulmonary bypass. Ann Thorac Surg 82 (2006) 2315-2322
20. Chung J.H., Gikakis N., Rao A.K., Drake T.A., Colman R.W., and Edmunds Jr. L.H. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 93 (1996) 2014-2018
21. Philippou H., Adami A., Davidson S.J., Pepper J.R., Burman J.F., and Lane D.A. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thromb Haemost 84 (2000) 124-128
22. Nieuwland R., Berckmans R.J., Rotteveel-Eijkman R.C., et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 96 (1997) 3534-3541
23. Sturk-Maquelin K.N., Nieuwland R., Romijn F.P.H.T.M., Eijsman L., Hack C.E., and Sturk A. Pro- and non-coagulant forms of non-cell-bound tissue factor in vivo. J Thromb Haemost 1 (2003) 1920-1926
24. Khan M.M., Hattori T., Niewiarowski S., Edmunds L.H., and Colman R.W. Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII. Thromb Haemost 95 (2006) 462-468
25. de Haan J., Boonstra P.W., Monnink S.H., Ebels T., and van Oeveren W. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg 59 (1995) 901-907
26. De Somer F., Van Belleghem Y., Caes F., et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg 123 (2002) 951-958
27. Aldea G.S., Soltow L.O., Chandler W.L., et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 123 (2002) 742-755
28. Albes J.M., Stöhr I.M., Kaluza M., et al. Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating. J Thorac Cardiovasc Surg 126 (2003) 1504-1512
29. Kottke-Marchant K., and Duncan A. Antithrombin deficiency. Issues in laboratory diagnosis. Arch Pathol Lab Med 126 (2002) 1326-1336
30. Baker I.A., Eastham R., Elwood P.C., Etherington M., O'Brien J.R., and Sweetnam P.M. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J 47 (1982) 490-494
31. Woodward M., Lowe G.D., Rumley A., et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 97 (1997) 785-797
32. Meade T.W., Cooper J., Miller G.J., Howarth D.J., and Stirling Y. Antithrombin III and arterial disease. Lancet 338 (1991) 850-851
33. Thompson S.G., Fechtrup C., Squire E., et al. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris. Arterioscler Thromb Vasc Biol 16 (1996) 357-362
34. Pelkonen K.M., Wartiovaara-Kautto U., Nieminen M.S., Ahonen K., and Sinisalo J. Low normal level of protein C or of antithrombin increases risk for recurrent cardiovascular events. Blood Coagul Fibrinolysis 16 (2005) 275-280
35. Eritsland J., Gjonnes G., Sandset P.M., Seljeflot I., and Arnesen H. Activated protein C resistance and graft occlusion after coronary artery bypass surgery. Thromb Res 79 (1995) 223-226
36. Moor E., Blomback M., Silveira A., et al. Haemostatic function in patients undergoing coronary artery bypass grafting: peroperative perturbations and relations to saphenous vein graft closure. Thromb Res 98 (2000) 39-49
37. Moor E., Silveira A., van't Hooft F., et al. Coagulation factor V (Arg506-Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting. Thromb Haemost 80 (1998) 220-224